Today, we develop breakthrough medicines, vaccines and technology that improve the health and well-being of animals worldwide.
News Releases
MSD Animal Health, a division of MSD & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the Mexico’s SADER Approval of EXZOLT® 5% Pour-On (Fluralaner 50 mg/mL) for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (Myiasis)
Featured Stories
Poultry is a cornerstone of global food security. It provides affordable, high-quality protein in the form of both meat and eggs, feeding billions of people worldwide.
Featured Stories
Healthier animals mean a sustainable food supply, protection for humans against diseases passed from animals, and longer, healthier lives for pets.
News Releases
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced a comprehensive scientific review of dairy cattle parasites has revealed that “hidden” infections are costing the global cattle industry billions of dollars every year.
Allflex Livestock Intelligence is the global leader in the design, development, manufacture and delivery of animal identification and monitoring devices.
News Releases
MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug Administration (FDA) has granted a conditional approval for EXZOLT™ CATTLE-CA1 (fluralaner topical solution). This innovative product is in the newest class of parasiticides known as isoxazolines.
Pioneering medicines, vaccines, technology, and insights-driven solutions that aim to improve the health and well-being of ruminants, enable a sustainable meat and dairy supply, and protect public health.
Our singular focus is to empower those who care for animals, helping them manage their vital responsibility with confidence.
News Releases
Presenting more than 10 new studies and continuing to solve unmet medical needs in the Ruminant space. Join us at EBC 2025 in France.